Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

ABSTRACT:

Background

Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India. India has faced challenges obtaining the needed levels of compliance with its mass drug administration (MDA) program to interrupt LF transmission, which utilizes diethylcarbamazine (DEC) or DEC plus albendazole. Previously identified predictors of and barriers to compliance with the MDA program were used to refine a pre-MDA educational campaign. The objectives of this study were to assess the impact of these refinements and of a lymphedema morbidity management program on MDA compliance.

Methods/principal findings

A randomized, 30-cluster survey was performed in each of 3 areas: the community-based pre-MDA education plus community-based lymphedema management education (Com-MD

SUBMITTER: Cantey PT 

PROVIDER: S-EPMC2900179 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature